Clinical Trial Update: Clofarabine for Relapsed or Refractory T-Cell or B-Cell Non-Hodgkin Lymphoma (NHL) [Phase 1, Phase 2]

View source ↗

Summary

This update summarizes Phase 1/2 trial results for clo farabine in relapsed or refractory T-cell or B-cell non-Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma
• Non-hodgkin Lymphoma
• T-cell Non-hodgkin Lymphoma

Drugs mentioned

• Clolar (Clofarabine)

Snippet

Sponsor: Oncology Specialists, S.C. | Conditions: Lymphoma, B-Cell, Lymphoma, Non-Hodgkin | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-07-09